Program finalized for the Toronto Symposium on HBV Cure: The Mechanisms Behind Combination Therapies, taking place at the International HBV Meeting
Recently Published Protocols
-
An Optimized Ex Vivo ELISpot assay to identify IFN gamma positive, HBV-specific T cells in Chronic Hepatitis B patients
... [Read more]
12 April, 2023 -
Multiplexed immunostaining of formalin-fixed paraffin-embedded liver biopsy tissues with metal-conjugated antibodies for tissue imaging mass cytometry
This protocol describes the a... [Read more]12 April, 2023 -
A modified kit-based HBV protein-free DNA extraction from liver tissues and cell cultures for HBV cccDNA Southern blot and qPCR
- cccDNA quantifica... [Read more]
21 September, 2022 -
A sensitive and rapid Southern blot assay based on branched DNA technology for the detection of HBV DNA in cell culture and liver tissue samples
- Sothern blot is c... [Read more]
21 September, 2022 -
An Optimized Ex Vivo Flurospot assay to identify multi-functional HBV-specific T cells in Chronic Hepatitis B patients
During a traditional FluroSpo... [Read more]07 March, 2022 -
Fluorescent-bait labelling for the ex vivo detection of HBV antigen-specific B cells
Fluorescently conjugated anti... [Read more]30 April, 2021 -
Tetramer enrichment for HBV-specific CD8+ T cells
The frequency of HBV-specific... [Read more]03 July, 2020 -
A fluorescent in situ hybridization (FISH) assay for detection of HBV DNA in cell culture models
- Although a pletho... [Read more]
19 June, 2020 -
HBV Ribonuclease H assay resolved by denaturing PAGE
- This assay characterizes the products of HBV RNase H activity on a DNA:RNA heteroduplex.
- Products are resolved by denaturing PAGE to assess specificity of cleavage and effects of inhibitory compounds on the enzyme
06 June, 2019 -
HBV Ribonuclease H FRET Assay
- This assay detect... [Read more]
06 June, 2019